APM – aptorum group limited - class a ordinary shares (US:NASDAQ)
Stock Stats
News
Aptorum Group Announces a Collaboration Between DiamiR Biosciences and Instant NanoBiosensors (INB) to Validate INB’s Automated APOE Testing Platform for Alzheimer’s Disease
Aptorum Group (NASDAQ:APM) had its "sell (d-)" rating reaffirmed by analysts at Weiss Ratings.
Aptorum Group (NASDAQ:APM) had its "sell (e+)" rating reaffirmed by analysts at Weiss Ratings.
Aptorum Group (NASDAQ:APM) had its "sell (e+)" rating reaffirmed by analysts at Weiss Ratings.
DiamiR Biosciences and Aptorum Group Announce Two Abstracts Accepted for Presentation at the Clinical Trials on Alzheimer's Disease (CTAD) 2025 Conference [Yahoo! Finance]
Form 6-K Aptorum Group Ltd For: Feb 06
Form 6-K Aptorum Group Ltd For: Sep 30
Form S-4/A Aptorum Group Ltd
Form F-3 Aptorum Group Ltd
Form 6-K/A Aptorum Group Ltd For: Dec 05
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.